Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis

Abstract

Delgocitinib ointment improved clinical signs and symptoms in pediatric patients with AD and was well tolerated. These study results indicate that delgocitinib ointment can be a promising therapeutic option for pediatric patients with AD.